ISPOR - HTA27 How Have Canada's Drug Agency Guidelines Impacted Choice of Model Structure and Use of Partitioned Survival Models in Oncology Submissions?

Full Text

HTA27 How Have Canada's Drug Agency Guidelines Impacted Choice of Model Structure and Use of Partitioned Survival Models in Oncology Submissions?

Abstract

Authors

Chloi Theriou Eesha Kodi Alicia N. Pepper

Back to Volume 28, Supplemental Issue 6S1

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now